The lungs are one of the most common sites for cancer to spread, and a wide range of primary cancers can metastasize there. In a study of 228 patients with metastatic lung nodules, the most frequent sources were colorectal cancer (25.8%), head and neck cancers (19.4%), urologic cancers including kidney and prostate (14.7%), other gastrointestinal cancers (10.9%), and breast cancer (10.5%). Melanoma, gynecologic cancers, and sarcomas accounted for most of the remainder.
Why the Lungs Are Such a Common Target
The lungs receive the entire output of blood from the heart every single minute. They also contain the densest network of tiny blood vessels (capillaries) in the body, and they’re the first capillary network that most lymphatic drainage encounters after entering the veins. This means cancer cells circulating in the bloodstream are almost guaranteed to pass through the lungs, where they can get trapped in the fine mesh of delicate membranes that make up lung tissue.
The process starts when cells break away from the original tumor and enter the bloodstream. Most of these circulating cells are destroyed by the immune system. But a small fraction survive, lodge in the lung’s capillary beds, and push through the vessel walls into surrounding tissue. Once there, they can tap into nearby oxygen-rich air and establish new tumors. This blood-borne route is the primary way cancers reach the lungs, which is why so many different tumor types end up there.
Colorectal Cancer
Colorectal cancer is the single most common source of lung metastases. Among patients with metastatic colorectal cancer, about 31.7% have lung involvement. Rectal cancers are more likely to spread to the lungs than colon cancers: 37.5% versus 30.1%. Broader estimates suggest that 6 to 8% of all colon cancers and 10 to 18% of all rectal cancers will eventually metastasize to the lungs. Colorectal cancer can spread both to the lung tissue itself and to the airways (the bronchial tree), making it one of the more versatile spreaders in this regard.
Breast Cancer
Among all newly diagnosed breast cancer patients, about 1.8% will have lung metastases. That sounds small, but breast cancer is so common that the absolute numbers are significant. Among breast cancer patients who develop any distant metastasis, the lungs are involved 36.4% of the time, making them one of the top destinations alongside bone and liver. The median survival after a lung metastasis diagnosis in breast cancer patients is about 21 months, though this varies widely depending on the cancer subtype and how it responds to treatment.
Head and Neck Cancers
Squamous cell carcinomas of the head and neck are the second most common source of metastatic lung nodules, accounting for roughly 19.4% of cases in one large study. These cancers originate in the mouth, throat, larynx, or sinuses and tend to spread to the lungs through the bloodstream. Head and neck cancer as a primary site is also associated with a notably worse prognosis when lung metastases develop, with one analysis finding it was an independent predictor of shorter survival (nearly four times the risk of death compared to other primary sites).
Kidney and Other Urologic Cancers
Urologic cancers, which include kidney, prostate, bladder, and testicular cancers, collectively account for about 14.7% of metastatic lung nodules. Kidney cancer (renal cell carcinoma) is particularly prone to spreading to the lungs and can also grow directly into the airways. Testicular cancers, especially certain germ cell tumors, also have a well-known tendency to metastasize to the lungs, though they often respond well to treatment even after spreading.
Osteosarcoma
Osteosarcoma, the most common primary bone cancer, has a striking tendency to spread to the lungs. About 15 to 17% of osteosarcoma patients already have lung metastases at the time they’re first diagnosed, and some studies report rates as high as 47% depending on the patient’s age. This makes the lungs the overwhelmingly dominant site of distant spread for bone cancers. Lung metastases from osteosarcoma are a major factor in determining outcomes, and regular chest imaging is a standard part of follow-up care for these patients.
Melanoma
Melanoma accounts for roughly 6.5% of metastatic lung nodules. While melanoma is best known for spreading to the brain and liver, the lungs are also a frequent destination. Because melanoma cells travel aggressively through the bloodstream, lung involvement can appear even when the original skin tumor seemed thin or localized.
Other Cancers That Spread to the Lungs
Gynecologic cancers, including ovarian, endometrial, and cervical cancers, collectively make up about 6.1% of lung metastases. Uterine leiomyosarcoma, a rare smooth-muscle tumor of the uterus, is particularly notable for its tendency to spread to lung tissue. Non-colorectal gastrointestinal cancers (stomach, pancreas, esophagus) account for about 10.9% of cases. Rarer sources include thyroid cancer, adrenal cancer, and choriocarcinoma, a cancer related to pregnancy.
Even primary lung cancer itself can metastasize within the lungs, spreading from one lobe or one lung to the other. Lymphomas can also involve the airways, though they more commonly affect the lymph nodes within the chest.
What Lung Metastases Feel Like
Many lung metastases cause no symptoms at all, especially when they’re small. They’re frequently discovered on routine imaging scans done as part of cancer follow-up, appearing as round nodules scattered through the lung tissue. When symptoms do develop, they tend to include a persistent cough, shortness of breath, or chest pain. If a metastasis grows into or near an airway, it can cause coughing up blood. Because these symptoms overlap with dozens of other conditions, imaging is the primary way metastases are identified. Small nodules deep in the lung tissue can grow for months without producing any noticeable changes in how you feel.
How Lung Metastases Are Found
CT scans of the chest are the standard tool for detecting lung metastases. They can pick up nodules just a few millimeters across. When nodules are found, the key question is whether they represent spread from a known cancer, a new primary lung cancer, or something benign. A biopsy, where a small tissue sample is taken from the nodule, can confirm the origin. Pathologists examine the cells under a microscope and use special staining techniques to match the tissue to its original cancer type. For example, cells from a colorectal metastasis look and stain differently than cells from a kidney cancer or melanoma, even though they’re all sitting in lung tissue.
For patients with a known cancer history, new lung nodules are treated with a high degree of suspicion, especially if multiple round nodules appear in both lungs simultaneously. A single nodule is harder to classify and sometimes requires monitoring over several weeks to see whether it grows before a biopsy is performed.